Teresa Selvin Sneha, Thomas Sonu, Bikeyeva Viktoriya, Abdullah Ahmed, Radivojevic Aleksandra, Abu Jad Anas A, Ravanavena Anvesh, Ravindra Chetna, Igweonu-Nwakile Emmanuelar O, Ali Safina, Paul Salomi, Yakkali Shreyas, Balani Prachi
Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Behavioral Neurosciences and Psychology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Cureus. 2022 Jul 23;14(7):e27188. doi: 10.7759/cureus.27188. eCollection 2022 Jul.
Osteoporosis is one of the most common metabolic bone diseases. Many studies were conducted to find the association between peptic ulcer disease (PUD), infection, proton-pump inhibitor (PPI) use, and increased risk for fracture, but results remain ambiguous. We performed this systematic review to understand the association between PUD and osteoporosis. We comprehensively searched relevant articles on April 19, 2022, by exploring different databases including PubMed, PubMed Central (PMC), and Medline using relevant keywords. After applying inclusion and exclusion criteria and undergoing quality assessment, we retained 25 studies published in and after 2015. For our systematic review, we included a total of 5,600,636 participants. The studies included in our review demonstrated a significant association between PUD, infection, and the risk of osteoporosis. Long-term PPI use was also found to be a risk factor for osteoporosis. Malabsorption of nutrients, increase in inflammatory cytokines, and alterations in hormone status were found to be the notable factors behind the association. Early management of infection and cautious use of long-term PPIs may protect against osteoporosis. Further randomized controlled trials (RCTs) are necessary to establish a causal relationship.
骨质疏松症是最常见的代谢性骨病之一。人们进行了许多研究来探寻消化性溃疡病(PUD)、感染、质子泵抑制剂(PPI)的使用与骨折风险增加之间的关联,但结果仍不明确。我们开展这项系统评价以了解PUD与骨质疏松症之间的关联。2022年4月19日,我们通过使用相关关键词检索包括PubMed、PubMed Central(PMC)和Medline在内的不同数据库,全面搜索了相关文章。在应用纳入和排除标准并进行质量评估后,我们保留了2015年及之后发表的25项研究。在我们的系统评价中,总共纳入了5600636名参与者。我们纳入的研究表明PUD、感染与骨质疏松症风险之间存在显著关联。长期使用PPI也被发现是骨质疏松症的一个风险因素。营养物质吸收不良、炎性细胞因子增加以及激素状态改变被发现是这种关联背后的显著因素。早期控制感染和谨慎使用长期PPI可能预防骨质疏松症。有必要开展进一步的随机对照试验(RCT)来确定因果关系。